Folding@home on Twitter: "However, S309, a recently discovered #SARSCoV2 neutralizing antibody (currently in clinical trials) does not compete with ACE2 for RBD binding. S309 (pink) binds to a different side of the
S309 - Stamford Sport Wheels ล้อแม็กซ์
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains | Nature Communications
Structural and functional analysis of a potent sarbecovirus neutralizing antibody | bioRxiv
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody | Nature
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody | Nature